An alternative strategy might be to use cytology images to calculate the approximate percentage of tumor cells for each sampling event and then derive a correction factor for quantitating tumor biomarker levels, particularly as normal cells can contribute to biomarker expression levels (e.g., ER, PR) measured by the D4 immunodiagnostic assay. This evidence concerns the gene PGR and neoplasm.